Carl Icahn Is Locked in Battle Against His Own Kind
Published
Carl Icahn’s publicly traded firm finds itself the subject of short seller Hindenburg Research. It's just the latest activist-vs-activist battle.
#carlicahn #hindenburgresearch
Published
Carl Icahn’s publicly traded firm finds itself the subject of short seller Hindenburg Research. It's just the latest activist-vs-activist battle.
#carlicahn #hindenburgresearch
Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc..